| ASSET | MONTH | % RETURN |
|---|---|---|
EVI Industries (EVI) | March 1991 | 225% |
Cato (CATO) | April 1991 | 211.15% |
Envela (ELA) | December 1991 | 192.31% |
NVR (NVR) | January 1991 | 183.33% |
Enzo Biochem (ENZ) | December 1991 | 172.72% |
Oppenheimer (OPY) | February 1991 | 168.16% |
Gencor Industries (GENC) | December 1991 | 155.53% |
ImmuCell (ICCC) | March 1991 | 142.44% |
Vaxart (VXRT) | November 1991 | 140% |
Hallador Energy (HNRG) | September 1991 | 119.99% |
Enzo Biochem (ENZ) | September 1991 | 114.28% |
Comtech Telecommunications (CMTL) | March 1991 | 114.27% |
Sony (SONY) | September 1991 | 112.13% |
Biomerica (BMRA) | September 1991 | 109.28% |
Cadiz (CDZI) | February 1991 | 100% |
Dominari (DOMH) | March 1991 | 100% |
Pure Cycle (PCYO) | June 1991 | 100% |
Research Frontiers (REFR) | April 1991 | 97.14% |
Cato (CATO) | February 1991 | 95.01% |
BioLife Solutions (BLFS) | October 1991 | 93% |
Toll Brothers (TOL) | February 1991 | 91.99% |
STAAR Surgical (STAA) | September 1991 | 90.91% |
BioLife Solutions (BLFS) | September 1991 | 90.33% |
Cato (CATO) | May 1991 | 88.92% |
Gencor Industries (GENC) | August 1991 | 84.63% |
